COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort

E. Ouaalaya (Bordeaux, France), M. Zysman (Bordeaux, France), É. Berteaud (Bordeaux, France), L. Falque (Bordeaux, France), L. Nguyen (Bordeaux, France), J. Dupis (Pessac, France), M. Sabatini (Bayonne, France), A. Bernady (Cambo les bains, France), A. Ozier (Bordeaux, France), C. Nocent-Ejnaini (Bayonne, France), C. Roy (Libourne, France), F. Le Guillou (la Rochelle, France), E. Monge (Bordeaux, France), M. Aliati (Lormont, France), A. Prudhomme (Aressy, France), L. Petrov (Bayonne, France), M. Quinquenel (Léognan, France), M. Staali (Libourne, France), F. Pilard (Libourne, France), M. Sapène (Bordeaux, France), J. Casteigt (Saint-Médard-en-Jalles, France), J. Moinard (Bordeaux, France), Y. Daoudi (Saint-Médard-en-Jalles, France), E. Iglesias (Libourne, France), É. Blanchard (Bordeaux, France), J. Macey (Bordeaux, France), R. Veillon (Bordeaux, France), X. Demant (Bordeaux, France), C. Bon (Bordeaux, France), L. Grassion (Bordeaux, France), M. Molimard (Bordeaux, France), C. Raherison-Semjen (Bordeaux, France)

Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Session: Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Session type: E-poster session
Number: 1435
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Ouaalaya (Bordeaux, France), M. Zysman (Bordeaux, France), É. Berteaud (Bordeaux, France), L. Falque (Bordeaux, France), L. Nguyen (Bordeaux, France), J. Dupis (Pessac, France), M. Sabatini (Bayonne, France), A. Bernady (Cambo les bains, France), A. Ozier (Bordeaux, France), C. Nocent-Ejnaini (Bayonne, France), C. Roy (Libourne, France), F. Le Guillou (la Rochelle, France), E. Monge (Bordeaux, France), M. Aliati (Lormont, France), A. Prudhomme (Aressy, France), L. Petrov (Bayonne, France), M. Quinquenel (Léognan, France), M. Staali (Libourne, France), F. Pilard (Libourne, France), M. Sapène (Bordeaux, France), J. Casteigt (Saint-Médard-en-Jalles, France), J. Moinard (Bordeaux, France), Y. Daoudi (Saint-Médard-en-Jalles, France), E. Iglesias (Libourne, France), É. Blanchard (Bordeaux, France), J. Macey (Bordeaux, France), R. Veillon (Bordeaux, France), X. Demant (Bordeaux, France), C. Bon (Bordeaux, France), L. Grassion (Bordeaux, France), M. Molimard (Bordeaux, France), C. Raherison-Semjen (Bordeaux, France). COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort. 1435

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk charts of five-year mortality in COPD patients
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019


Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


Nutrition status and mortality rate during 5-years follow-up in patients with COPD.
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019

Cause-specific mortality rates in patients with COPD in primary care: a prospective analysis of the Birmingham COPD Cohort Study
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020


Predicting 12-month mortality in a Scottish COPD cohort
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008



10-year follow-up of hospitalised COPD-patients: Comorbidities, mortality and cause of death
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018



The association of comorbidity clusters with long-term survival and incidence of exacerbation in a COPD cohort. The HUNT Study, Norway.
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


Mortality and prognostic factors in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010

Survival characteristics and predictors of mortality in COPD subjects
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019

Relationship between supernormal lung function and long-term risk of hospitalisations and mortality: a population-based cohort study
Source: Eur Respir J, 57 (4) 2004055; 10.1183/13993003.04055-2020
Year: 2021



Projections of 10-year mortality in patients with COPD in the UK using the CHOPIN policy model
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


Four-year follow up of a COPD cohort, participation and mortality
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009

Multinational, database cohort study to study mortality and risk factors of mortality in patients with asthma
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016


Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality
Source: Eur Respir J 2010; 36: 1002-1006
Year: 2010



Risk factors for COPD mortality in women in the UK
Source: Eur Respir J 2006; 28: Suppl. 50, 463s
Year: 2006

A prospective study on COPD and risk of mortality five years later
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009

Validated the power of terminal status criteria in the prediction of 1-year mortality in patiens with COPD
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020


Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
Source: Eur Respir J, 57 (3) 2001339; 10.1183/13993003.01339-2020
Year: 2021



Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014